Olema Pharmaceuticals, INC. 8-K Filing
Ticker: OLMA · Form: 8-K · Filed: Nov 18, 2025 · CIK: 1750284
| Field | Detail |
|---|---|
| Company | Olema Pharmaceuticals, INC. (OLMA) |
| Form Type | 8-K |
| Filed Date | Nov 18, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Olema Pharmaceuticals, INC. (ticker: OLMA) to the SEC on Nov 18, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ich registered Common Stock, par value $0.0001 per share OLMA The Nasdaq Global Se).
How long is this filing?
Olema Pharmaceuticals, INC.'s 8-K filing is 2 pages with approximately 463 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 463 words · 2 min read · ~2 pages · Grade level 13 · Accepted 2025-11-18 16:23:43
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share OLMA The Nasdaq Global Se
Filing Documents
- d86905d8k.htm (8-K) — 22KB
- 0001193125-25-286206.txt ( ) — 129KB
- olma-20251118.xsd (EX-101.SCH) — 3KB
- olma-20251118_lab.xml (EX-101.LAB) — 17KB
- olma-20251118_pre.xml (EX-101.PRE) — 11KB
- d86905d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Olema Pharmaceuticals, Inc. Date: November 18, 2025 By: /s/ Shane Kovacs Shane Kovacs Chief Operating and Financial Officer